WASPLab Recall Issued Over Software Issue

Source: FDA · Arizona, United States

Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.

Copan WASP has initiated a Class II recall of one WASPLab device due to a software issue that may prevent users from overwriting results.

What this FDA recall tells you, and what most readers miss

This notice was issued by FDA on August 19, 2026 and geographically references Arizona, United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.

Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.

Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, medical-device.

What Happened

Copan WASP initiated a voluntary recall due to a software issue within the WebApp that potentially prevents the user from overwriting the results.

Which Products Are Affected

The recall affects one unit of the WASPLab automated device (Model/Catalog Number: W087, Software Version: WebApp version 2.33.1, 2.33.3 and 2.34.2). The product is intended for incubation and digital imaging of agar culture plates. Distribution was limited to Arizona.

What You Should Do

No specific consumer actions or contact information are provided in the recall notice.

Why This Matters

The software defect affects result management in a device used for microbiological investigations of human specimens.

Source

FDA recall number Z-2854-2026

Original source: FDA Official Notice ↗

All FDA Recalls →

Nationwide notices with similar length or severity timing 8

Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.

Frequently Asked Questions

Common questions about this FDA recall.

What is this FDA recall about?
Copan WASP has initiated a Class II recall of one WASPLab device due to a software issue that may prevent users from overwriting results.
Which agency issued this alert?
This alert was issued by FDA. The original notice is available at the source link at the bottom of this article.
How severe is this alert?
This alert is classified as "medium" severity. Stay informed and follow agency guidance.
What area is affected?
This alert affects Arizona, United States. Check with FDA for the most current geographic scope.
Where can I find more FDA Recalls updates?
Browse the full FDA Recalls feed on Areazine at areazine.com/recalls/fda/ for the latest updates from FDA and other agencies.